Pharma Mar SA (PHM) Stock Price & News

PHM:BME

Pharma Mar SA

65,40 €

-0,76%

(-0,50) 1D

6-ноя., 17:36:00 GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for PHM...

Open

65,15 €

High

66,20 €

Low

64,15 €

Mkt. cap

1,19 млд

Avg. vol.

34,48 миң

Volume

38,73 миң

Dividend

1,53%

Quarterly dividend

0,25 €

Ex-dividend date

2023-ж., 7-июн.

P/E ratio

16,40

52-wk high

105,20 €

52-wk low

62,00 €

EPS

3,99 €

Shares outstanding

18,00 млн

No. of employees

505

Open

65,15 €

High

66,20 €

Low

64,15 €

Mkt. cap

1,19 млд

Avg. vol.

34,48 миң

Volume

38,73 миң

Dividend

1,53%

Quarterly dividend

0,25 €

Ex-dividend date

2023-ж., 7-июн.

P/E ratio

16,40

52-wk high

105,20 €

52-wk low

62,00 €

EPS

3,99 €

Shares outstanding

18,00 млн

No. of employees

505

Related stocks

Laboratorio Reig Jofre SA

2,61 €

+1,56%

News stories

From web sources and news partners

Finviz

29 мүнөт мурун

PSQ Holdings Shrinks Losses And Cash Burn, But Slowing Growth, A Steep Q4 Target And NYSE Listing Risk Define The Setup

The Motley Fool

6 мүнөт мурун

After the Midterm Rally, the Dow Is on Track to Beat the Nasdaq for the First Time Since 2022. Here's What History Says Could Come Next.

kalkine.ca

45 мүнөт мурун

Can Small Caps Valued at USD 271.24 Million to USD 709.02 Million Back Up Their Records, Led by ACNB Corporation (NASDAQ:ACNB), California BanCorp (NASDAQ:BCAL), Avidbank Holdings (NASDAQ:AVBH), Acme United (NYSEAMERICAN:ACU) an

Barchart.com

1 саат мурун

Nasdaq Rout Gives Way to Unusual Options Activity and Bullish Bets on Nvidia, AT&T and Alphabet Stocks

About Pharma Mar SA

CEO-

Employees505

Founded1986

Headquarters-

SectorHealth Care

Industry-

Websitepharmamar.com

All values in EUR	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.	2026-ж. сен.
Revenue	90,48 млн	42,90 млн	49,60 млн	54,42 млн
Cost of goods sold	3,77 млн	3,66 млн	4,73 млн	3,67 млн
Cost of revenue	3,77 млн	3,66 млн	4,73 млн	3,67 млн
Research and development expenses	25,59 млн	20,88 млн	26,38 млн	24,86 млн
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	17,31 млн	15,31 млн	17,12 млн	15,53 млн
Operating expense	43,09 млн	38,62 млн	46,28 млн	43,10 млн
Total operating expenses	46,87 млн	42,28 млн	51,01 млн	46,77 млн
Operating income	43,61 млн	622,00 миң	-1,40 млн	7,65 млн
Other non operating income	-	-	-	-
EBT including unusual items	44,28 млн	1,60 млн	-993,00 миң	8,14 млн
EBT excluding unusual items	44,28 млн	1,60 млн	-993,00 миң	8,14 млн
Income tax expense	-15,39 млн	65,00 миң	-21,00 миң	-1,00 миң
Effective tax rate	-34,75%	4,07%	2,11%	-0,01%
Other operating expenses	195,00 миң	2,43 млн	2,77 млн	2,71 млн
Net income	59,66 млн	1,53 млн	-972,00 миң	8,14 млн
Net profit margin	65,95%	3,57%	-1,96%	14,96%
Earnings per share	-	-	-	-
Interest and investment income	3,44 млн	976,00 миң	412,00 миң	492,00 миң
Interest expense	-724,00 миң	-	-	-
Net interest expenses	2,72 млн	976,00 миң	412,00 миң	492,00 миң
Depreciation and amortization charges	-	-	-	-
EBITDA	45,64 млн	2,71 млн	700,00 миң	9,78 млн
Gain or loss from assets sale	-754,00 миң	-	-	-

Finance

Ask anything